Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...
New Data Show Treatment with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy Resulted in Favorable Structural Remodeling, Improvements in Cardiac Function and Stabilization of ...
The application of deep learning to CMR imaging from the UK Biobank cohort facilitated the largest imaging-based prevalence study of hypertrophic cardiomyopathy (HCM). The deep learning-based study of ...
3 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands Correspondence to Dr T Luijkx, Department of Radiology, Room E 01.132, University ...
—Dr. Wang spoke to MedPage Today to discuss the diagnosis of apical HCM, and distinct features of this disease subtype. Apical hypertrophic cardiomyopathy (HCM) is a morphological subtype of HCM that ...
Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects in nonobstructive HCM remain uncertain. We conducted a phase 3, ...
The diagnosis of a potentially lethal cardiovascular disease in a young athlete presents a complex dilemma regarding athlete safety, patient autonomy, team or institutional risk tolerance and medical ...
Arrhythmias, or irregular heart rhythms, are common complications of HCM. The thickened heart muscle disrupts the electrical pathways that coordinate heartbeat, leading to arrhythmias. Atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results